Viewing StudyNCT03241446



Ignite Creation Date: 2024-05-06 @ 10:24 AM
Last Modification Date: 2024-10-26 @ 12:29 PM
Study NCT ID: NCT03241446
Status: WITHDRAWN
Last Update Posted: 2018-10-09
First Post: 2017-07-25

Brief Title: Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis RA
Sponsor: Navidea Biopharmaceuticals
Organization: Navidea Biopharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-09
Start Date Type: ESTIMATED
Primary Completion Date: 2018-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2018-03
Completion Date Type: ESTIMATED
First Submit Date: 2017-07-25
First Submit QC Date: August 2 2017
Study First Post Date: 2017-08-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-10-04
Last Update Post Date: 2018-10-09
Last Update Post Date Type: ACTUAL